Armata Pharmaceuticals, Inc. (NYSEAMERICAN:ARMP – Get Free Report) was the recipient of a large decrease in short interest during the month of May. As of May 15th, there was short interest totalling 800 shares, a decrease of 92.5% from the April 30th total of 10,700 shares. Based on an average trading volume of 16,600 shares, […]
HC Wainwright restated their buy rating on shares of Armata Pharmaceuticals (NYSEAMERICAN:ARMP – Free Report) in a research report sent to investors on Friday, Benzinga reports. They currently have a $7.00 price target on the stock. Armata Pharmaceuticals Stock Up 1.4 % Shares of ARMP opened at $3.74 on Friday. The stock has a market […]
Shares of Armata Pharmaceuticals, Inc. (NYSEAMERICAN:ARMP – Get Free Report) fell 4.1% during trading on Monday . The company traded as low as $2.55 and last traded at $2.59. 3,188 shares changed hands during mid-day trading, a decline of 94% from the average session volume of 57,459 shares. The stock had previously closed at $2.70. […]
Armata Pharmaceuticals, Inc. (NYSEAMERICAN:ARMP – Free Report) – Analysts at HC Wainwright dropped their Q4 2023 earnings estimates for shares of Armata Pharmaceuticals in a report issued on Wednesday, November 15th. HC Wainwright analyst J. Pantginis now expects that the company will post earnings per share of ($0.36) for the quarter, down from their previous […]
Armata Pharmaceuticals, Inc. (NYSEAMERICAN:ARMP – Get Free Report) was the recipient of a large growth in short interest during the month of June. As of June 30th, there was short interest totalling 29,700 shares, a growth of 13.4% from the June 15th total of 26,200 shares. Currently, 0.3% of the shares of the company are […]